267 related articles for article (PubMed ID: 31375867)
1. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of dedicated breast positron emission tomography.
Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S
Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684
[TBL] [Abstract][Full Text] [Related]
3. Dedicated breast PET value to evaluate BI-RADS 4 breast lesions.
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares A; Ruibal A; Vázquez-Caruncho M
Eur J Radiol; 2018 Nov; 108():201-207. PubMed ID: 30396656
[TBL] [Abstract][Full Text] [Related]
4. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
5. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
7. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
[TBL] [Abstract][Full Text] [Related]
8. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
9. Digital Mammography Has Persistently Increased High-Grade and Overall DCIS Detection Without Altering Upgrade Rate.
Neal CH; Joe AI; Patterson SK; Pujara AC; Helvie MA
AJR Am J Roentgenol; 2021 Apr; 216(4):912-918. PubMed ID: 33594910
[No Abstract] [Full Text] [Related]
10. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
[TBL] [Abstract][Full Text] [Related]
11. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
13. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
14. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
Seo YY; Yoo IR; Park SY; Oh JK; Kim SH; Sohn HS
Breast Cancer; 2017 May; 24(3):353-361. PubMed ID: 27312540
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
[TBL] [Abstract][Full Text] [Related]
17. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
Evans AJ; Pinder SE; Ellis IO; Wilson AR
J Med Screen; 2001; 8(3):149-51. PubMed ID: 11678555
[TBL] [Abstract][Full Text] [Related]
18. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
[No Abstract] [Full Text] [Related]
19. Assessing the correlation between FDG PET findings of IDC breast carcinoma and histopathology of coexisting ductal carcinoma in-situ.
Sarikaya I; Sarikaya A; Albatineh AN; Tastekin E; Sezer YA
Nucl Med Rev Cent East Eur; 2022; 25(1):6-11. PubMed ID: 35137931
[TBL] [Abstract][Full Text] [Related]
20. Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?
Hajaj M; Karim A; Pascaline S; Noor L; Patel S; Dakka M
Eur J Radiol; 2017 Oct; 95():271-277. PubMed ID: 28987679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]